Bilgilendirme: Kurulum ve veri kapsamındaki çalışmalar devam etmektedir. Göstereceğiniz anlayış için teşekkür ederiz.

Publication:
Blood Count-Derived Immunoinflammatory Markers in Thyroid-Associated Ophthalmopathy

dc.authorscopusid25633265700
dc.authorscopusid57192211319
dc.authorscopusid57224959315
dc.authorscopusid55537171600
dc.contributor.authorYeter, V.
dc.contributor.authorKocak, N.
dc.contributor.authorArslan, M.T.
dc.contributor.authorKan, E.K.
dc.date.accessioned2025-12-11T00:28:53Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Yeter] Volkan, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kocak] Nurullah, Department of Ophthalmology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Arslan] Mehmet Tayfun, Department of Ophthalmology, Kirklareli State Hospital, Kirklareli, Kirklareli, Turkey; [Kan] Elif Kiliç, Department of Endocrinology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractPurpose: To investigate the diagnostic and prognostic significance of the blood-count derived systemic immunoinflammatory parameters in patients with thyroid-Associated ophthalmopathy (TAO). Methods: In this retrospective case-control study, the blood-count parameters and neutrophil-To-lymphocyte ratio (NLR), platelet-To-lymphocyte ratio (PLR), monocyte-To-lymphocyte ratio, and systemic immune-inflammatory index (SII), thyroid peroxidase antibody, and anti-Thyroglobulin antibody were evaluated in 46 patients with TAO and 46 matched controls. The associations of the immunoinflammatory parameters with clinical outcomes were analyzed among TAO patients. Results: Significant differences were found in NLR, PLR, SII, and lymphocyte count between the controls and the TAO group (p 0.05 for all). In logistic regression analysis, these inflammatory parameters did not have any prognostic effect on the clinical outcomes of the TAO (p 0.05 for all). The patients, who needed systemic treatment due to any ocular involvement of TAO during the follow-up period, had significantly lower platelet count (p = 0.001) and PLR (p = 0.02) at the time of initial diagnosis when compared to the no treatment-needed group of the TAO patients. The initial platelet count was significantly associated with the subsequent steroid need due to TAO during the follow-up period (β =-0.02, p = 0.03). Conclusions: NLR, PLR, and SII may serve as potential inflammatory markers in the identification of the TAO, although they have no evident prognostic significance in TAO. However, the relatively lower platelet count at initial diagnosis may be associated with the need for systemic therapy during the follow-up in patients with TAO. © 2021 Korean Ophthalmological Society (KOS). All rights reserved.en_US
dc.identifier.doi10.3341/KJO.2021.0012
dc.identifier.endpage206en_US
dc.identifier.issn1011-8942
dc.identifier.issn2092-9382
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85108737739
dc.identifier.scopusqualityQ2
dc.identifier.startpage198en_US
dc.identifier.urihttps://doi.org/10.3341/KJO.2021.0012
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36632
dc.identifier.volume35en_US
dc.language.isoenen_US
dc.publisherKorean Ophthalmological Society (KOS)en_US
dc.relation.ispartofKorean Journal of Ophthalmology : KJOen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBlood Plateletsen_US
dc.subjectGraves Ophthalmopathyen_US
dc.subjectLymphocytesen_US
dc.subjectNeutrophilsen_US
dc.subjectSystemic Immune-Inflammatory Indexen_US
dc.titleBlood Count-Derived Immunoinflammatory Markers in Thyroid-Associated Ophthalmopathyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files